NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus

Cell Metabolism

Volumn 22, Issue 1, 2015, Pages 31-53

  Cantó, Carles ^a   Menzies, Keir J ^b   Auwerx, Johan ^b  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NICOTINIC ACID; PROTEIN PRECURSOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; TANKYRASE;

AGING; BIOAVAILABILITY; BIOSYNTHESIS; CELL COMPARTMENTALIZATION; CELL ENERGY; CELL FATE; CELL METABOLISM; CELL NUCLEUS; DEGENERATIVE DISEASE; DYSLIPIDEMIA; FOOD; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; MALIGNANT NEOPLASTIC DISEASE; METABOLIC REGULATION; MITOCHONDRION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; ANIMAL; ENERGY METABOLISM; METABOLIC DISORDER; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASM;

AGING; ANIMALS; CELL NUCLEUS; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; METABOLIC DISEASES; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; NAD; NEOPLASMS; NEURODEGENERATIVE DISEASES; POLY(ADP-RIBOSE) POLYMERASES; SIRTUINS;

EID: 84937522438     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.05.023     Document Type: Review

References (290)

1. S. Aksoy, C.L. Szumlanski, and R.M. Weinshilboum Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization J. Biol. Chem. 269 1994 14835 14840
2. P. Aksoy, C. Escande, T.A. White, M. Thompson, S. Soares, J.C. Benech, and E.N. Chini Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38 Biochem. Biophys. Res. Commun. 349 2006 353 359
3. P. Aksoy, T.A. White, M. Thompson, and E.N. Chini Regulation of intracellular levels of NAD: a novel role for CD38 Biochem. Biophys. Res. Commun. 345 2006 1386 1392
4. C.C. Alano, A. Tran, R. Tao, W. Ying, J.S. Karliner, and R.A. Swanson Differences among cell types in NAD(+) compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes J. Neurosci. Res. 85 2007 3378 3385
5. C.C. Alano, P. Garnier, W. Ying, Y. Higashi, T.M. Kauppinen, and R.A. Swanson NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death J. Neurosci. 30 2010 2967 2978
6. R. Altschul, A. Hoffer, and J.D. Stephen Influence of nicotinic acid on serum cholesterol in man Arch. Biochem. Biophys. 54 1955 558 559
7. J.C. Amé, V. Rolli, V. Schreiber, C. Niedergang, F. Apiou, P. Decker, S. Muller, T. Höger, J. Ménissier-de Murcia, and G. de Murcia PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase J. Biol. Chem. 274 1999 17860 17868
8. R.M. Anderson, K.J. Bitterman, J.G. Wood, O. Medvedik, and D.A. Sinclair Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae Nature 423 2003 181 185
9. S.A. Andrabi, G.K.E. Umanah, C. Chang, D.A. Stevens, S.S. Karuppagounder, J.-P. Gagné, G.G. Poirier, V.L. Dawson, and T.M. Dawson Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis Proc. Natl. Acad. Sci. USA 111 2014 10209 10214
10. T. Araki, Y. Sasaki, and J. Milbrandt Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration Science 305 2004 1010 1013
11. G. Asher, D. Gatfield, M. Stratmann, H. Reinke, C. Dibner, F. Kreppel, R. Mostoslavsky, F.W. Alt, and U. Schibler SIRT1 regulates circadian clock gene expression through PER2 deacetylation Cell 134 2008 317 328
12. G. Asher, H. Reinke, M. Altmeyer, M. Gutierrez-Arcelus, M.O. Hottiger, and U. Schibler Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding Cell 142 2010 943 953
13. I. Bacher, A. Zidar, M. Kratzel, and M. Hohenegger Channelling of substrate promiscuity of the skeletal-muscle ADP-ribosyl cyclase isoform Biochem. J. 381 2004 147 154
14. P. Bai, and C. Cantó The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease Cell Metab. 16 2012 290 295
15. P. Bai, C. Canto, A. Brunyánszki, A. Huber, M. Szántó, Y. Cen, H. Yamamoto, S.M. Houten, B. Kiss, H. Oudart, and et al. PARP-2 regulates SIRT1 expression and whole-body energy expenditure Cell Metab. 13 2011 450 460
16. P. Bai, C. Cantó, H. Oudart, A. Brunyánszki, Y. Cen, C. Thomas, H. Yamamoto, A. Huber, B. Kiss, R.H. Houtkooper, and et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation Cell Metab. 13 2011 461 468
17. A.S. Banks, N. Kon, C. Knight, M. Matsumoto, R. Gutiérrez-Juárez, L. Rossetti, W. Gu, and D. Accili SirT1 gain of function increases energy efficiency and prevents diabetes in mice Cell Metab. 8 2008 333 341
18. X. Bao, Y. Wang, X. Li, X.-M. Li, Z. Liu, T. Yang, C.F. Wong, J. Zhang, Q. Hao, and X.D. Li Identification of 'erasers' for lysine crotonylated histone marks using a chemical proteomics approach Elife 3 2014 10.7554/eLife.02999
19. M.T.P. Barbosa, S.M. Soares, C.M. Novak, D. Sinclair, J.A. Levine, P. Aksoy, and E.N. Chini The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity FASEB J. 21 2007 3629 3639
20. M. Barile, S. Passarella, G. Danese, and E. Quagliariello Rat liver mitochondria can synthesize nicotinamide adenine dinucleotide from nicotinamide mononucleotide and ATP via a putative matrix nicotinamide mononucleotide adenylyltransferase Biochem. Mol. Biol. Int. 38 1996 297 306
21. J.H. Bauer, S.N.S. Morris, C. Chang, T. Flatt, J.G. Wood, and S.L. Helfand dSir2 and Dmp53 interact to mediate aspects of CR-dependent lifespan extension in D. melanogaster Aging (Albany, N.Y. Online) 1 2009 38 48
22. C.L. Baum, J. Selhub, and I.H. Rosenberg The hydrolysis of nicotinamide adenine nucleotide by brush border membranes of rat intestine Biochem. J. 204 1982 203 207
23. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra, V.V. Prabhu, J.S. Allard, G. Lopez-Lluch, K. Lewis, and et al. Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342
24. B. Beirowski, J. Gustin, S.M. Armour, H. Yamamoto, A. Viader, B.J. North, S. Michán, R.H. Baloh, J.P. Golden, R.E. Schmidt, and et al. Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling Proc. Natl. Acad. Sci. USA 108 2011 E952 E961
25. P. Belenky, F.G. Racette, K.L. Bogan, J.M. McClure, J.S. Smith, and C. Brenner Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+ Cell 129 2007 473 484
26. C.A. Benavente, M.K. Jacobson, and E.L. Jacobson NAD in skin: therapeutic approaches for niacin Curr. Pharm. Des. 15 2009 29 38
27. C.A. Benavente, S.A. Schnell, and E.L. Jacobson Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin PLoS ONE 7 2012 e42276
28. D.A. Bender Biochemistry of tryptophan in health and disease Mol. Aspects Med. 6 1983 101 197
29. R.C. Benjamin, and D.M. Gill Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks J. Biol. Chem. 255 1980 10502 10508
30. Z. Benyó, A. Gille, J. Kero, M. Csiky, M.C. Suchánková, R.M. Nüsing, A. Moers, K. Pfeffer, and S. Offermanns GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing J. Clin. Invest. 115 2005 3634 3640
31. N.A. Berger Poly(ADP-ribose) in the cellular response to DNA damage Radiat. Res. 101 1985 4 15
32. F. Berger, C. Lau, M. Dahlmann, and M. Ziegler Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms J. Biol. Chem. 280 2005 36334 36341
33. A. Bessede, M. Gargaro, M.T. Pallotta, D. Matino, G. Servillo, C. Brunacci, S. Bicciato, E.M.C. Mazza, A. Macchiarulo, C. Vacca, and et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway Nature 511 2014 184 190
34. T.-Q. Bi, X.-M. Che, X.-H. Liao, D.-J. Zhang, H.-L. Long, H.-J. Li, and W. Zhao Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil Oncol. Rep. 26 2011 1251 1257
35. P. Bieganowski, and C. Brenner Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans Cell 117 2004 495 502
36. R.S. Birjmohun, B.A. Hutten, J.J. Kastelein, and E.S. Stroes Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials J. Am. Coll. Cardiol. 45 2005 185 197
37. K.J. Bitterman, R.M. Anderson, H.Y. Cohen, M. Latorre-Esteves, and D.A. Sinclair Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1 J. Biol. Chem. 277 2002 45099 45107
38. G. Blander, and L. Guarente The Sir2 family of protein deacetylases Annu. Rev. Biochem. 73 2004 417 435
39. A. Bobrowska, G. Donmez, A. Weiss, L. Guarente, and G. Bates SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivo PLoS ONE 7 2012 e34805
40. K.L. Bogan, and C. Brenner Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition Annu. Rev. Nutr. 28 2008 115 130
41. G. Boily, E.L. Seifert, L. Bevilacqua, X.H. He, G. Sabourin, C. Estey, C. Moffat, S. Crawford, S. Saliba, K. Jardine, and et al. SirT1 regulates energy metabolism and response to caloric restriction in mice PloS One 3 2008 10.1371/journal.pone.0001759
42. N. Bonhoure, A. Byrnes, R.D. Moir, W. Hodroj, F. Preitner, V. Praz, G. Marcelin, S.C. Chua Jr., N. Martinez-Lopez, R. Singh, and et al. Loss of the RNA polymerase III repressor MAF1 confers obesity resistance Genes Dev. 29 2015 934 947
43. M.T. Borra, M.R. Langer, J.T. Slama, and J.M. Denu Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases Biochemistry 43 2004 9877 9887
44. M. Boutant, and C. Canto SIRT1 metabolic actions: Integrating recent advances from mouse models Mol. Metab. 3 2014 5 18
45. N. Braidy, G.J. Guillemin, H. Mansour, T. Chan-Ling, A. Poljak, and R. Grant Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats PLoS ONE 6 2011 e19194
46. + precursor nicotinamide riboside protects from noise-induced hearing loss Cell Metab. 20 2014 1059 1068
47. H.E. Bryant, N. Schultz, H.D. Thomas, K.M. Parker, D. Flower, E. Lopez, S. Kyle, M. Meuth, N.J. Curtin, and T. Helleday Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Nature 434 2005 913 917
48. C. Burnett, S. Valentini, F. Cabreiro, M. Goss, M. Somogyvári, M.D. Piper, M. Hoddinott, G.L. Sutphin, V. Leko, J.J. McElwee, and et al. Absence of effects of Sir2 overexpression on lifespan in C. Elegans and Drosophila Nature 477 2011 482 485
49. E. Cabrera-Rode, G. Molina, C. Arranz, M. Vera, P. González, R. Suárez, M. Prieto, S. Padrón, R. León, J. Tillan, and et al. Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes Autoimmunity 39 2006 333 340
50. C. Cakir-Kiefer, H. Muller-Steffner, N. Oppenheimer, and F. Schuber Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling Biochem. J. 358 2001 399 406
51. C. Cantó, and J. Auwerx Caloric restriction, SIRT1 and longevity Trends Endocrinol. Metab. 20 2009 325 331
52. C. Cantó, and J. Auwerx Targeting sirtuin 1 to improve metabolism: all you need is NAD(+) Pharmacol. Rev. 64 2012 166 187
53. C. Cantó, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, J.C. Milne, P.J. Elliott, P. Puigserver, and J. Auwerx AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 458 2009 1056 1060
54. C. Cantó, L.Q. Jiang, A.S. Deshmukh, C. Mataki, A. Coste, M. Lagouge, J.R. Zierath, and J. Auwerx Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle Cell Metab. 11 2010 213 219
55. C. Cantó, R.H. Houtkooper, E. Pirinen, D.Y. Youn, M.H. Oosterveer, Y. Cen, P.J. Fernandez-Marcos, H. Yamamoto, P.A. Andreux, P. Cettour-Rose, and et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity Cell Metab. 15 2012 838 847
56. C. Cantó, A.A. Sauve, and P. Bai Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes Mol. Aspects Med. 34 2013 1168 1201
57. C. Ceni, H. Muller-Steffner, F. Lund, N. Pochon, A. Schweitzer, M. De Waard, F. Schuber, M. Villaz, and M.J. Moutin Evidence for an intracellular ADP-ribosyl cyclase/NAD+-glycohydrolase in brain from CD38-deficient mice J. Biol. Chem. 278 2003 40670 40678
58. R. Cerutti, E. Pirinen, C. Lamperti, S. Marchet, A.A. Sauve, W. Li, V. Leoni, E.A. Schon, F. Dantzer, J. Auwerx, and et al. NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease Cell Metab. 19 2014 1042 1049
59. H.-C. Chang, and L. Guarente SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging Cell 153 2013 1448 1460
60. D. Chen, J. Bruno, E. Easlon, S.J. Lin, H.L. Cheng, F.W. Alt, and L. Guarente Tissue-specific regulation of SIRT1 by calorie restriction Genes Dev. 22 2008 1753 1757
61. S. Chen, J. Seiler, M. Santiago-Reichelt, K. Felbel, I. Grummt, and R. Voit Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7 Mol. Cell 52 2013 303 313
62. Y. Chi, and A.A. Sauve Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection Curr. Opin. Clin. Nutr. Metab. Care 16 2013 657 661
63. Y.J. Chiang, M.-L. Nguyen, S. Gurunathan, P. Kaminker, L. Tessarollo, J. Campisi, and R.J. Hodes Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice Mol. Cell. Biol. 26 2006 2037 2043
64. M. Cohen-Armon, L. Visochek, D. Rozensal, A. Kalal, I. Geistrikh, R. Klein, S. Bendetz-Nezer, Z. Yao, and R. Seger DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation Mol. Cell 25 2007 297 308
65. P.B. Collins, and S. Chaykin The management of nicotinamide and nicotinic acid in the mouse J. Biol. Chem. 247 1972 778 783
66. L. Conforti, A. Tarlton, T.G. Mack, W. Mi, E.A. Buckmaster, D. Wagner, V.H. Perry, and M.P. Coleman A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse Proc. Natl. Acad. Sci. USA 97 2000 11377 11382
67. L. Conforti, A. Wilbrey, G. Morreale, L. Janeckova, B. Beirowski, R. Adalbert, F. Mazzola, M. Di Stefano, R. Hartley, E. Babetto, and et al. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice J. Cell Biol. 184 2009 491 500
68. L. Conforti, L. Janeckova, D. Wagner, F. Mazzola, L. Cialabrini, M. Di Stefano, G. Orsomando, G. Magni, C. Bendotti, N. Smyth, and M. Coleman Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration FEBS J. 278 2011 2666 2679
69. S.R. Costford, S. Bajpeyi, M. Pasarica, D.C. Albarado, S.C. Thomas, H. Xie, T.S. Church, S.A. Jubrias, K.E. Conley, and S.R. Smith Skeletal muscle NAMPT is induced by exercise in humans Am. J. Physiol. Endocrinol. Metab. 298 2010 E117 E126
70. N.J. Curtin, and C. Szabo Therapeutic applications of PARP inhibitors: anticancer therapy and beyond Mol. Aspects Med. 34 2013 1217 1256
71. M.H. Cynamon, T.B. Sorg, and A. Patapow Utilization and metabolism of NAD by Haemophilus parainfluenzae J. Gen. Microbiol. 134 1988 2789 2799
72. A. De Flora, L. Guida, L. Franco, and E. Zocchi The CD38/cyclic ADP-ribose system: a topological paradox Int. J. Biochem. Cell Biol. 29 1997 1149 1166
73. H. De Jesús-Cortés, P. Xu, J. Drawbridge, S.J. Estill, P. Huntington, S. Tran, J. Britt, R. Tesla, L. Morlock, J. Naidoo, and et al. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease Proc. Natl. Acad. Sci. USA 109 2012 17010 17015
74. K. Devalaraja-Narashimha, and B.J. Padanilam PARP1 deficiency exacerbates diet-induced obesity in mice J. Endocrinol. 205 2010 243 252
75. S. Diani-Moore, P. Ram, X. Li, P. Mondal, D.Y. Youn, A.A. Sauve, and A.B. Rifkind Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect J. Biol. Chem. 285 2010 38801 38810
76. J. Du, Y. Zhou, X. Su, J.J. Yu, S. Khan, H. Jiang, J. Kim, J. Woo, J.H. Kim, B.H. Choi, and et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase Science 334 2011 806 809
77. J. Durieux, S. Wolff, and A. Dillin The cell-non-autonomous nature of electron transport chain-mediated longevity Cell 144 2011 79 91
78. C.A. Elvehjem The Biological Significance of Nicotinic Acid: Harvey Lecture, November 16, 1939 Bull. N. Y. Acad. Med. 16 1940 173 189
79. M. Emanuelli, F. Carnevali, F. Saccucci, F. Pierella, A. Amici, N. Raffaelli, and G. Magni Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase J. Biol. Chem. 276 2001 406 412
80. S. Erener, A. Mirsaidi, M. Hesse, A.N. Tiaden, H. Ellingsgaard, R. Kostadinova, M.Y. Donath, P.J. Richards, and M.O. Hottiger ARTD1 deletion causes increased hepatic lipid accumulation in mice fed a high-fat diet and impairs adipocyte function and differentiation FASEB J. 26 2012 2631 2638
81. C. Escande, C.C. Chini, V. Nin, K.M. Dykhouse, C.M. Novak, J. Levine, J. van Deursen, G.J. Gores, J. Chen, Z. Lou, and E.N. Chini Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice J. Clin. Invest. 120 2010 545 558
82. C. Escande, V. Nin, N.L. Price, V. Capellini, A.P. Gomes, M.T. Barbosa, L. O'Neil, T.A. White, D.A. Sinclair, and E.N. Chini Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome Diabetes 62 2013 1084 1093
83. Euler-Chelpin, H.v. (1929). Nobel Lecture: Fermentation of Sugars and Fermentative Enzymes. (http://www.nobelprize.org/nobel-prizes/chemistry/laureates/1929/euler-chelpin-lecture.html: The Nobel Foundation 1929).
84. W. Fan, and J. Luo SIRT1 regulates UV-induced DNA repair through deacetylating XPA Mol. Cell 39 2010 247 258
85. E.F. Fang, M. Scheibye-Knudsen, L.E. Brace, H. Kassahun, T. SenGupta, H. Nilsen, J.R. Mitchell, D.L. Croteau, and V.A. Bohr Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction Cell 157 2014 882 896
86. H. Farmer, N. McCabe, C.J. Lord, A.N.J. Tutt, D.A. Johnson, T.B. Richardson, M. Santarosa, K.J. Dillon, I. Hickson, C. Knights, and et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature 434 2005 917 921
87. J.N. Feige, M. Lagouge, C. Canto, A. Strehle, S.M. Houten, J.C. Milne, P.D. Lambert, C. Mataki, P.J. Elliott, and J. Auwerx Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation Cell Metab. 8 2008 347 358
88. J.L. Feldman, J. Baeza, and J.M. Denu Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins J. Biol. Chem. 288 2013 31350 31356
89. R. Felici, A. Lapucci, M. Ramazzotti, and A. Chiarugi Insight into molecular and functional properties of NMNAT3 reveals new hints of NAD homeostasis within human mitochondria PLoS ONE 8 2013 e76938
90. Y. Feng, I.A. Paul, and M.H. LeBlanc Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat Brain Res. Bull. 69 2006 117 122
91. F. Fischer, M. Gertz, B. Suenkel, M. Lakshminarasimhan, M. Schutkowski, and C. Steegborn Sirt5 deacylation activities show differential sensitivities to nicotinamide inhibition PLoS ONE 7 2012 e45098
92. C.C. Fjeld, W.T. Birdsong, and R.H. Goodman Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor Proc. Natl. Acad. Sci. USA 100 2003 9202 9207
93. P.C. Fong, D.S. Boss, T.A. Yap, A. Tutt, P. Wu, M. Mergui-Roelvink, P. Mortimer, H. Swaisland, A. Lau, M.J. O'Connor, and et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers N. Engl. J. Med. 361 2009 123 134
94. J.C. Forbes, and G.M. Duncan Effect of a tryptophan-niacin deficient diet on the adrenal response of rats exposed to cold and alcohol intoxication Q. J. Stud. Alcohol 22 1961 254 260
95. E. Fouquerel, E.M. Goellner, Z. Yu, J.-P. Gagné, M. Barbi de Moura, T. Feinstein, D. Wheeler, P. Redpath, J. Li, G. Romero, and et al. ARTD1/PARP1 negatively regulates glycolysis by inhibiting hexokinase 1 independent of NAD+ depletion Cell Rep. 8 2014 1819 1831
96. M. Fulco, Y. Cen, P. Zhao, E.P. Hoffman, M.W. McBurney, A.A. Sauve, and V. Sartorelli Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt Dev. Cell 14 2008 661 673
97. E.A.M. Gale, P.J. Bingley, C.L. Emmett, T. Collier, E.N.D.I.T.E. Group European Nicotinamide Diabetes Intervention Trial (ENDIT) Group European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes Lancet 363 2004 925 931
98. A. Garten, S. Petzold, A. Körner, S.-i. Imai, and W. Kiess Nampt: linking NAD biology, metabolism and cancer Trends Endocrinol. Metab. 20 2009 130 138
99. H.L. Gensler, T. Williams, A.C. Huang, and E.L. Jacobson Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice Nutr. Cancer 34 1999 36 41
100. + destruction Science 348 2015 453 457
101. Z. Gerhart-Hines, J.E. Dominy Jr., S.M. Blättler, M.P. Jedrychowski, A.S. Banks, J.-H. Lim, H. Chim, S.P. Gygi, and P. Puigserver The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+) Mol. Cell 44 2011 851 863
102. B.A. Gibson, and W.L. Kraus New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs Nat. Rev. Mol. Cell Biol. 13 2012 411 424
103. J. Gilley, and M.P. Coleman Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons PLoS Biol. 8 2010 e1000300
104. J. Goldberger The etiology of pellagra. 1914 Public Health Rep. 121 Suppl 1 2006 77 79 discussion 76
105. A.P. Gomes, N.L. Price, A.J.Y. Ling, J.J. Moslehi, M.K. Montgomery, L. Rajman, J.P. White, J.S. Teodoro, C.D. Wrann, B.P. Hubbard, and et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging Cell 155 2013 1624 1638
106. B. Gong, Y. Pan, P. Vempati, W. Zhao, L. Knable, L. Ho, J. Wang, M. Sastre, K. Ono, A.A. Sauve, and G.M. Pasinetti Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models Neurobiol. Aging 34 2013 1581 1588
107. G. Gradwohl, J.M. Ménissier de Murcia, M. Molinete, F. Simonin, M. Koken, J.H. Hoeijmakers, and G. de Murcia The second zinc-finger domain of poly(ADP-ribose) polymerase determines specificity for single-stranded breaks in DNA Proc. Natl. Acad. Sci. USA 87 1990 2990 2994
108. C.J. Gross, and L.M. Henderson Digestion and absorption of NAD by the small intestine of the rat J. Nutr. 113 1983 412 420
109. J.A. Gwirtz, and M.N. Garcia-Casal Processing maize flour and corn meal food products Ann. N Y Acad. Sci. 1312 2014 66 75
110. C.D. Haffner, J.D. Becherer, E.E. Boros, R. Cadilla, T. Carpenter, D. Cowan, D.N. Deaton, Y. Guo, W. Harrington, B.R. Henke, and et al. Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors J. Med. Chem. 58 2015 3548 3571
111. M.C. Haigis, and D.A. Sinclair Mammalian sirtuins: biological insights and disease relevance Annu. Rev. Pathol. 5 2010 253 295
112. M.C. Haigis, R. Mostoslavsky, K.M. Haigis, K. Fahie, D.C. Christodoulou, A.J. Murphy, D.M. Valenzuela, G.D. Yancopoulos, M. Karow, G. Blander, and et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells Cell 126 2006 941 954
113. J.A. Hall, J.E. Dominy, Y. Lee, and P. Puigserver The sirtuin family's role in aging and age-associated pathologies J. Clin. Invest. 123 2013 973 979
114. W.C. Hallows, W. Yu, B.C. Smith, M.K. Devries, J.J. Ellinger, S. Someya, M.R. Shortreed, T. Prolla, J.L. Markley, L.M. Smith, and et al. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction Mol. Cell 41 2011 139 149
115. N. Hara, K. Yamada, M. Terashima, H. Osago, M. Shimoyama, and M. Tsuchiya Molecular identification of human glutamine- and ammonia-dependent NAD synthetases. Carbon-nitrogen hydrolase domain confers glutamine dependency J. Biol. Chem. 278 2003 10914 10921
116. N. Hara, K. Yamada, T. Shibata, H. Osago, T. Hashimoto, and M. Tsuchiya Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells J. Biol. Chem. 282 2007 24574 24582
117. N. Hara, K. Yamada, T. Shibata, H. Osago, and M. Tsuchiya Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma PLoS ONE 6 2011 e22781
118. A. Harden, and W.J. Young The Alcoholic Ferment of Yeast-Juice. Part II.-The Conferment of Yeast-Juice Proc. R. Soc. Lond., B 78 1906 369 375
119. M. Hasmann, and I. Schemainda FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis Cancer Res. 63 2003 7436 7442
120. P.O. Hassa, C. Buerki, C. Lombardi, R. Imhof, and M.O. Hottiger Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1 J. Biol. Chem. 278 2003 45145 45153
121. J. Hegyi, R.A. Schwartz, and V. Hegyi Pellagra: dermatitis, dementia, and diarrhea Int. J. Dermatol. 43 2004 1 5
122. L.M. Henderson Tryptophan's role as a vitamin precursor (Krehl et al., 1945) J. Nutr. 127 Suppl 1997 1043S 1045S
123. L.M. Henderson, and C.J. Gross Metabolism of niacin and niacinamide in perfused rat intestine J. Nutr. 109 1979 654 662
124. M. Herbert, E. Sauer, G. Smethurst, A. Kraiss, A.K. Hilpert, and J. Reidl Nicotinamide ribosyl uptake mutants in Haemophilus influenzae Infect. Immun. 71 2003 5398 5401
125. D. Herranz, M. Muñoz-Martin, M. Cañamero, F. Mulero, B. Martinez-Pastor, O. Fernandez-Capetillo, and M. Serrano Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer Nat. Commun. 1 2010 3
126. K. Hikosaka, M. Ikutani, M. Shito, K. Kazuma, M. Gulshan, Y. Nagai, K. Takatsu, K. Konno, K. Tobe, H. Kanno, and T. Nakagawa Deficiency of nicotinamide mononucleotide adenylyltransferase 3 (nmnat3) causes hemolytic anemia by altering the glycolytic flow in mature erythrocytes J. Biol. Chem. 289 2014 14796 14811
127. M.D. Hirschey, T. Shimazu, E. Jing, C.A. Grueter, A.M. Collins, B. Aouizerat, A. Stančáková, E. Goetzman, M.M. Lam, B. Schwer, and et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome Mol. Cell 44 2011 177 190
128. C.K. Ho, and S.A. Hashim Pyridine nucleotide depletion in pancreatic islets associated with streptozotocin-induced diabetes Diabetes 21 1972 789 793
129. J. Hong, B.-W. Kim, H.-J. Choo, J.-J. Park, J.-S. Yi, D.-M. Yu, H. Lee, G.-S. Yoon, J.-S. Lee, and Y.-G. Ko Mitochondrial complex I deficiency enhances skeletal myogenesis but impairs insulin signaling through SIRT1 inactivation J. Biol. Chem. 289 2014 20012 20025
130. M.K. Horwitt, A.E. Harper, and L.M. Henderson Niacin-tryptophan relationships for evaluating niacin equivalents Am. J. Clin. Nutr. 34 1981 423 427
131. R.H. Houtkooper, C. Cantó, R.J. Wanders, and J. Auwerx The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways Endocr. Rev. 31 2010 194 223
132. R.H. Houtkooper, R.W. Williams, and J. Auwerx Metabolic networks of longevity Cell 142 2010 9 14
133. R.H. Houtkooper, E. Pirinen, and J. Auwerx Sirtuins as regulators of metabolism and healthspan Nat. Rev. Mol. Cell Biol. 13 2012 225 238
134. R.H. Houtkooper, L. Mouchiroud, D. Ryu, N. Moullan, E. Katsyuba, G. Knott, R.W. Williams, and J. Auwerx Mitonuclear protein imbalance as a conserved longevity mechanism Nature 497 2013 451 457
135. Y. Hu, H. Wang, Q. Wang, and H. Deng Overexpression of CD38 decreases cellular NAD levels and alters the expression of proteins involved in energy metabolism and antioxidant defense J. Proteome Res. 13 2014 786 795
136. A. Ieraci, and D.G. Herrera Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain PLoS Med. 3 2006 e101
137. M. Ikeda, H. Tsuji, S. Nakamura, A. Ichiyama, Y. Nishizuka, and O. Hayaishi STUDIES ON THE BIOSYNTHESIS OF NICOTINAMIDE ADENINE DINUCLEOTIDE. II. A ROLE OF PICOLINIC CARBOXYLASE IN THE BIOSYNTHESIS OF NICOTINAMIDE ADENINE DINUCLEOTIDE FROM TRYPTOPHAN IN MAMMALS J. Biol. Chem. 240 1965 1395 1401
138. S. Imai, C.M. Armstrong, M. Kaeberlein, and L. Guarente Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase Nature 403 2000 795 800
139. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline 1998 National Academies Press (US) Washington (DC)
140. D.G. Jackson, and J.I. Bell Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation J. Immunol. 144 1990 2811 2815
141. E.L. Jacobson Niacin deficiency and cancer in women J. Am. Coll. Nutr. 12 1993 412 416
142. E.L. Jacobson, A.J. Dame, J.S. Pyrek, and M.K. Jacobson Evaluating the role of niacin in human carcinogenesis Biochimie 77 1995 394 398
143. J.C. Jiang, E. Jaruga, M.V. Repnevskaya, and S.M. Jazwinski An intervention resembling caloric restriction prolongs life span and retards aging in yeast FASEB J. 14 2000 2135 2137
144. H. Jiang, J.H. Kim, K.M. Frizzell, W.L. Kraus, and H. Lin Clickable NAD analogues for labeling substrate proteins of poly(ADP-ribose) polymerases J. Am. Chem. Soc. 132 2010 9363 9372
145. H. Jiang, S. Khan, Y. Wang, G. Charron, B. He, C. Sebastian, J. Du, R. Kim, E. Ge, R. Mostoslavsky, and et al. SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine Nature 496 2013 110 113
146. M. Kaeberlein, M. McVey, and L. Guarente The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms Genes Dev. 13 1999 2570 2580
147. W.G. Kaelin Jr., and S.L. McKnight Influence of metabolism on epigenetics and disease Cell 153 2013 56 69
148. I. Kameshita, Z. Matsuda, T. Taniguchi, and Y. Shizuta Poly (ADP-Ribose) synthetase. Separation and identification of three proteolytic fragments as the substrate-binding domain, the DNA-binding domain, and the automodification domain J. Biol. Chem. 259 1984 4770 4776
149. Y. Kanfi, S. Naiman, G. Amir, V. Peshti, G. Zinman, L. Nahum, Z. Bar-Joseph, and H.Y. Cohen The sirtuin SIRT6 regulates lifespan in male mice Nature 483 2012 218 221
150. Y.A. Kang-Lee, R.W. McKee, S.M. Wright, M.E. Swendseid, D.J. Jenden, and R.S. Jope Metabolic effects of nicotinamide administration in rats J. Nutr. 113 1983 215 221
151. A. Kannt, K. Sicka, K. Kroll, D. Kadereit, and H. Gögelein Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic compounds Naunyn Schmiedebergs Arch. Pharmacol. 385 2012 717 727
152. E. Kellenberger, I. Kuhn, F. Schuber, and H. Muller-Steffner Flavonoids as inhibitors of human CD38 Bioorg. Med. Chem. Lett. 21 2011 3939 3942
153. N.A. Khan, M. Auranen, I. Paetau, E. Pirinen, L. Euro, S. Forsstrom, L. Pasila, V. Velagapudi, C.J. Carroll, J. Auwerx, and et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3 2014 EMBO Mol Med
154. L. Klaidman, M. Morales, S. Kem, J. Yang, M.-L. Chang, and J.D. Adams Jr. Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function Pharmacology 69 2003 150 157
155. U. Kolthur-Seetharam, F. Dantzer, M.W. McBurney, G. de Murcia, and P. Sassone-Corsi Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage Cell Cycle 5 2006 873 877
156. W.L. Kraus, and M.O. Hottiger PARP-1 and gene regulation: progress and puzzles Mol. Aspects Med. 34 2013 1109 1123
157. D. Kraus, Q. Yang, D. Kong, A.S. Banks, L. Zhang, J.T. Rodgers, E. Pirinen, T.C. Pulinilkunnil, F. Gong, Y.C. Wang, and et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity Nature 508 2014 258 262
158. S. Kumar, and D.B. Lombard Mitochondrial sirtuins and their relationships with metabolic disease and cancer Antioxid. Redox Signaling 22 2015 1060 1077
159. D.W. Lamming, M. Latorre-Esteves, O. Medvedik, S.N. Wong, F.A. Tsang, C. Wang, S.-J. Lin, and D.A. Sinclair HST2 mediates SIR2-independent life-span extension by calorie restriction Science 309 2005 1861 1864
160. E. Langley, M. Pearson, M. Faretta, U.-M. Bauer, R.A. Frye, S. Minucci, P.G. Pelicci, and T. Kouzarides Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence EMBO J. 21 2002 2383 2396
161. C. Lau, M. Niere, and M. Ziegler The NMN/NaMN adenylyltransferase (NMNAT) protein family Front Biosci (Landmark Ed) 14 2009 410 431
162. G. Laurent, N.J. German, A.K. Saha, V.C. de Boer, M. Davies, T.R. Koves, N. Dephoure, F. Fischer, G. Boanca, B. Vaitheesvaran, and et al. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase Mol. Cell 50 2013 686 698
163. B. Lauring, A.K.P. Taggart, J.R. Tata, R. Dunbar, L. Caro, K. Cheng, J. Chin, S.L. Colletti, J. Cote, S. Khalilieh, and et al. Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression Sci. Transl. Med. 4 2012 10.1126/scitranslmed.3003877
164. H.C. Lee Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization J. Biol. Chem. 287 2012 31633 31640
165. M. Lehmann, E. Pirinen, A. Mirsaidi, F.A. Kunze, P.J. Richards, J. Auwerx, and M.O. Hottiger ARTD1-induced poly-ADP-ribose formation enhances PPARγ ligand binding and co-factor exchange Nucleic Acids Res. 43 2015 129 142
166. X. Li, J.S. Millar, N. Brownell, F. Briand, and D.J. Rader Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes Biochem. Pharmacol. 80 2010 1450 1457
167. S.-J. Lin, E. Ford, M. Haigis, G. Liszt, and L. Guarente Calorie restriction extends yeast life span by lowering the level of NADH Genes Dev. 18 2004 12 16
168. G. Liszt, E. Ford, M. Kurtev, and L. Guarente Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase J. Biol. Chem. 280 2005 21313 21320
169. J. Llopis, S. Westin, M. Ricote, Z. Wang, C.Y. Cho, R. Kurokawa, T.M. Mullen, D.W. Rose, M.G. Rosenfeld, R.Y. Tsien, and C.K. Glass Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription Proc. Natl. Acad. Sci. USA 97 2000 4363 4368
170. S.-P. Lu, M. Kato, and S.-J. Lin Assimilation of endogenous nicotinamide riboside is essential for calorie restriction-mediated life span extension in Saccharomyces cerevisiae J. Biol. Chem. 284 2009 17110 17119
171. J. Luo, A.Y. Nikolaev, S. Imai, D. Chen, F. Su, A. Shiloh, L. Guarente, and W. Gu Negative control of p53 by Sir2alpha promotes cell survival under stress Cell 107 2001 137 148
172. T.G. Mack, M. Reiner, B. Beirowski, W. Mi, M. Emanuelli, D. Wagner, D. Thomson, T. Gillingwater, F. Court, L. Conforti, and et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene Nat. Neurosci. 4 2001 1199 1206
173. F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A.L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology Physiol. Rev. 88 2008 841 886
174. Z. Mao, C. Hine, X. Tian, M. Van Meter, M. Au, A. Vaidya, A. Seluanov, and V. Gorbunova SIRT6 promotes DNA repair under stress by activating PARP1 Science 332 2011 1443 1446
175. H. Massudi, R. Grant, N. Braidy, J. Guest, B. Farnsworth, and G.J. Guillemin Age-associated changes in oxidative stress and NAD+ metabolism in human tissue PLoS ONE 7 2012 e42357
176. M. Masutani, H. Suzuki, N. Kamada, M. Watanabe, O. Ueda, T. Nozaki, K. Jishage, T. Watanabe, T. Sugimoto, H. Nakagama, and et al. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes Proc. Natl. Acad. Sci. USA 96 1999 2301 2304
177. R.A. Mathias, T.M. Greco, A. Oberstein, H.G. Budayeva, R. Chakrabarti, E.A. Rowland, Y. Kang, T. Shenk, and I.M. Cristea Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity Cell 159 2014 1615 1625
178. M.C. McKenna, H.S. Waagepetersen, A. Schousboe, and U. Sonnewald Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools Biochem. Pharmacol. 71 2006 399 407
179. H. Mendoza-Alvarez, and R. Alvarez-Gonzalez Poly(ADP-ribose) polymerase is a catalytic dimer and the automodification reaction is intermolecular J. Biol. Chem. 268 1993 22575 22580
180. K.J. Menzies, K. Singh, A. Saleem, and D.A. Hood Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis J. Biol. Chem. 288 2013 6968 6979
181. E.M. Mercken, J. Hu, S. Krzysik-Walker, M. Wei, Y. Li, M.W. McBurney, R. de Cabo, and V.D. Longo SIRT1 but not its increased expression is essential for lifespan extension in caloric restricted mice Aging Cell 13 2013 193 196
182. E. Michishita, J.Y. Park, J.M. Burneskis, J.C. Barrett, and I. Horikawa Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins Mol. Biol. Cell 16 2005 4623 4635
183. R.K. Minor, J.A. Baur, A.P. Gomes, T.M. Ward, A. Csiszar, E.M. Mercken, K. Abdelmohsen, Y.K. Shin, C. Canto, M. Scheibye-Knudsen, and et al. SRT1720 improves survival and healthspan of obese mice Sci. Rep. 1 2011 70
184. R. Mostoslavsky, K.F. Chua, D.B. Lombard, W.W. Pang, M.R. Fischer, L. Gellon, P. Liu, G. Mostoslavsky, S. Franco, M.M. Murphy, and et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6 Cell 124 2006 315 329
185. L. Mouchiroud, R.H. Houtkooper, N. Moullan, E. Katsyuba, D. Ryu, C. Cantó, A. Mottis, Y.-S. Jo, M. Viswanathan, K. Schoonjans, and et al. The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling Cell 154 2013 430 441
186. P. Mukhopadhyay, M. Rajesh, Z. Cao, B. Horváth, O. Park, H. Wang, K. Erdelyi, E. Holovac, Y. Wang, L. Liaudet, and et al. Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis Hepatology 59 2014 1998 2009
187. T. Nakagawa, D.J. Lomb, M.C. Haigis, and L. Guarente SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle Cell 137 2009 560 570
188. Y. Nakahata, M. Kaluzova, B. Grimaldi, S. Sahar, J. Hirayama, D. Chen, L.P. Guarente, and P. Sassone-Corsi The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control Cell 134 2008 329 340
189. Y. Nakahata, S. Sahar, G. Astarita, M. Kaluzova, and P. Sassone-Corsi Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1 Science 324 2009 654 657
190. T.-S. Nam, S.H. Choi, S.-Y. Rah, S.-Y. Kim, W. Jang, M.-J. Im, H.J. Kwon, and U.-H. Kim Discovery of a small-molecule inhibitor for kidney ADP-ribosyl cyclase: Implication for intracellular calcium signal mediated by cyclic ADP-ribose Exp. Mol. Med. 38 2006 718 726
191. A. Nikiforov, C. Dölle, M. Niere, and M. Ziegler Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation J. Biol. Chem. 286 2011 21767 21778
192. B.J. North, B.L. Marshall, M.T. Borra, J.M. Denu, and E. Verdin The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase Mol. Cell 11 2003 437 444
193. P.R. Olmos, M.I. Hodgson, A. Maiz, M. Manrique, M.D. De Valdés, R. Foncea, A.M. Acosta, M.V. Emmerich, S. Velasco, O.P. Muñiz, and et al. Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics Diabetes Res. Clin. Pract. 71 2006 320 333
194. E. Owusu-Ansah, W. Song, and N. Perrimon Muscle mitohormesis promotes longevity via systemic repression of insulin signaling Cell 155 2013 699 712
195. M. Pacholec, J.E. Bleasdale, B. Chrunyk, D. Cunningham, D. Flynn, R.S. Garofalo, D. Griffith, M. Griffor, P. Loulakis, B. Pabst, and et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 J. Biol. Chem. 285 2010 8340 8351
196. P.W. Pan, J.L. Feldman, M.K. Devries, A. Dong, A.M. Edwards, and J.M. Denu Structure and biochemical functions of SIRT6 J. Biol. Chem. 286 2011 14575 14587
197. K.J. Pearson, J.A. Baur, K.N. Lewis, L. Peshkin, N.L. Price, N. Labinskyy, W.R. Swindell, D. Kamara, R.K. Minor, E. Perez, and et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span Cell Metab. 8 2008 157 168
198. S.J. Petesch, and J.T. Lis Activator-induced spread of poly(ADP-ribose) polymerase promotes nucleosome loss at Hsp70 Mol. Cell 45 2012 64 74
199. P.T. Pfluger, D. Herranz, S. Velasco-Miguel, M. Serrano, and M.H. Tschöp Sirt1 protects against high-fat diet-induced metabolic damage Proc. Natl. Acad. Sci. USA 105 2008 9793 9798
200. A.A. Pieper, S. Xie, E. Capota, S.J. Estill, J. Zhong, J.M. Long, G.L. Becker, P. Huntington, S.E. Goldman, C.-H. Shen, and et al. Discovery of a proneurogenic, neuroprotective chemical Cell 142 2010 39 51
201. J.B. Pillai, A. Isbatan, S.-i. Imai, and M.P. Gupta Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity J. Biol. Chem. 280 2005 43121 43130
202. E. Pirinen, C. Cantó, Y.S. Jo, L. Morato, H. Zhang, K.J. Menzies, E.G. Williams, L. Mouchiroud, N. Moullan, C. Hagberg, and et al. Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle Cell Metab. 19 2014 1034 1041
203. M. Pittelli, L. Formentini, G. Faraco, A. Lapucci, E. Rapizzi, F. Cialdai, G. Romano, G. Moneti, F. Moroni, and A. Chiarugi Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool J. Biol. Chem. 285 2010 34106 34114
204. M. Pittelli, R. Felici, V. Pitozzi, L. Giovannelli, E. Bigagli, F. Cialdai, G. Romano, F. Moroni, and A. Chiarugi Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis Mol. Pharmacol. 80 2011 1136 1146
205. N.L. Price, A.P. Gomes, A.J.Y. Ling, F.V. Duarte, A. Martin-Montalvo, B.J. North, B. Agarwal, L. Ye, G. Ramadori, J.S. Teodoro, and et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Cell Metab. 15 2012 675 690
206. W. Qin, T. Yang, L. Ho, Z. Zhao, J. Wang, L. Chen, W. Zhao, M. Thiyagarajan, D. MacGrogan, J.T. Rodgers, and et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction J. Biol. Chem. 281 2006 21745 21754
207. V. Quarona, G. Zaccarello, A. Chillemi, E. Brunetti, V.K. Singh, E. Ferrero, A. Funaro, A.L. Horenstein, and F. Malavasi CD38 and CD157: a long journey from activation markers to multifunctional molecules Cytometry B Clin. Cytom. 84 2013 207 217
208. S.B. Rajamohan, V.B. Pillai, M. Gupta, N.R. Sundaresan, K.G. Birukov, S. Samant, M.O. Hottiger, and M.P. Gupta SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1 Mol. Cell. Biol. 29 2009 4116 4129
209. K.M. Ramsey, K.F. Mills, A. Satoh, and S. Imai Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice Aging Cell 7 2008 78 88
210. K.M. Ramsey, J. Yoshino, C.S. Brace, D. Abrassart, Y. Kobayashi, B. Marcheva, H.K. Hong, J.L. Chong, E.D. Buhr, C. Lee, and et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis Science 324 2009 651 654
211. J.R. Revollo, A.A. Grimm, and S.-i. Imai The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells J. Biol. Chem. 279 2004 50754 50763
212. J.R. Revollo, A. Körner, K.F. Mills, A. Satoh, T. Wang, A. Garten, B. Dasgupta, Y. Sasaki, C. Wolberger, R.R. Townsend, and et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme Cell Metab. 6 2007 363 375
213. M. Riederer, W. Erwa, R. Zimmermann, S. Frank, and R. Zechner Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine Atherosclerosis 204 2009 412 417
214. J.F. Rippmann, K. Damm, and A. Schnapp Functional characterization of the poly(ADP-ribose) polymerase activity of tankyrase 1, a potential regulator of telomere length J. Mol. Biol. 323 2002 217 224
215. J.T. Rodgers, C. Lerin, W. Haas, S.P. Gygi, B.M. Spiegelman, and P. Puigserver Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 434 2005 113 118
216. B. Rogina, and S.L. Helfand Sir2 mediates longevity in the fly through a pathway related to calorie restriction Proc. Natl. Acad. Sci. USA 101 2004 15998 16003
217. A. Rongvaux, R.J. Shea, M.H. Mulks, D. Gigot, J. Urbain, O. Leo, and F. Andris Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis Eur. J. Immunol. 32 2002 3225 3234
218. J.G. Ryall, S. Dell'Orso, A. Derfoul, A. Juan, H. Zare, X. Feng, D. Clermont, M. Koulnis, G. Gutierrez-Cruz, M. Fulco, and et al. The NAD+-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells Cell Stem Cell 16 2015 171 183
219. D. Ryu, Y.S. Jo, G. Lo Sasso, S. Stein, H. Zhang, A. Perino, J.U. Lee, M. Zeviani, R. Romand, M.O. Hottiger, and et al. A SIRT7-dependent acetylation switch of GABPβ1 controls mitochondrial function Cell Metab. 20 2014 856 869
220. F. Sadanaga-Akiyoshi, H. Yao, S.-i. Tanuma, T. Nakahara, J.S. Hong, S. Ibayashi, H. Uchimura, and M. Fujishima Nicotinamide attenuates focal ischemic brain injury in rats: with special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumbra Neurochem. Res. 28 2003 1227 1234
221. M. Sajish, and P. Schimmel A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol Nature 519 2015 370 373
222. Y. Sasaki, T. Araki, and J. Milbrandt Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy J. Neurosci. 26 2006 8484 8491
223. Y. Sasaki, B.P.S. Vohra, F.E. Lund, and J. Milbrandt Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide J. Neurosci. 29 2009 5525 5535
224. A. Satoh, C.S. Brace, N. Rensing, P. Cliften, D.F. Wozniak, E.D. Herzog, K.A. Yamada, and S.-i. Imai Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH Cell Metab. 18 2013 416 430
225. A.A. Sauve, C. Munshi, H.C. Lee, and V.L. Schramm The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries Biochemistry 37 1998 13239 13249
226. M. Scheibye-Knudsen, E.F. Fang, D.L. Croteau, and V.A. Bohr Contribution of defective mitophagy to the neurodegeneration in DNA repair-deficient disorders Autophagy 10 2014 1468 1469
227. P.S. Schein, D.A. Cooney, and M.L. Vernon The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity Cancer Res. 27 1967 2324 2332
228. K. Schmeisser, J. Mansfeld, D. Kuhlow, S. Weimer, S. Priebe, I. Heiland, M. Birringer, M. Groth, A. Segref, Y. Kanfi, and et al. Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide Nat. Chem. Biol. 9 2013 693 700
229. M.T. Schmidt, B.C. Smith, M.D. Jackson, and J.M. Denu Coenzyme specificity of Sir2 protein deacetylases: implications for physiological regulation J. Biol. Chem. 279 2004 40122 40129
230. B. Schwer, B.J. North, R.A. Frye, M. Ott, and E. Verdin The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase J. Cell Biol. 158 2002 647 657
231. A.J. Seal, P.I. Creeke, F. Dibari, E. Cheung, E. Kyroussis, P. Semedo, and T. van den Briel Low and deficient niacin status and pellagra are endemic in postwar Angola Am. J. Clin. Nutr. 85 2007 218 224
232. B.C. Smith, W.C. Hallows, and J.M. Denu A continuous microplate assay for sirtuins and nicotinamide-producing enzymes Anal. Biochem. 394 2009 101 109
233. T. Soga, M. Kamohara, J. Takasaki, S. Matsumoto, T. Saito, T. Ohishi, H. Hiyama, A. Matsuo, H. Matsushime, and K. Furuichi Molecular identification of nicotinic acid receptor Biochem. Biophys. Res. Commun. 303 2003 364 369
234. S. Someya, W. Yu, W.C. Hallows, J. Xu, J.M. Vann, C. Leeuwenburgh, M. Tanokura, J.M. Denu, and T.A. Prolla Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction Cell 143 2010 802 812
235. L.R. Stein, and S.-i. Imai Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging EMBO J. 33 2014 1321 1340
236. T.W. Stone, and L.G. Darlington Endogenous kynurenines as targets for drug discovery and development Nat. Rev. Drug Discov. 1 2002 609 620
237. V.P. Sydenstricker The history of pellagra, its recognition as a disorder of nutrition and its conquest Am. J. Clin. Nutr. 6 1958 409 414
238. B. Szczesny, A. Brunyánszki, G. Olah, S. Mitra, and C. Szabo Opposing roles of mitochondrial and nuclear PARP1 in the regulation of mitochondrial and nuclear DNA integrity: implications for the regulation of mitochondrial function Nucleic Acids Res. 42 2014 13161 13173
239. M. Tan, C. Peng, K.A. Anderson, P. Chhoy, Z. Xie, L. Dai, J. Park, Y. Chen, H. Huang, Y. Zhang, and et al. Lysine glutarylation is a protein posttranslational modification regulated by SIRT5 Cell Metab. 19 2014 605 617
240. M. Tanno, J. Sakamoto, T. Miura, K. Shimamoto, and Y. Horio Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1 J. Biol. Chem. 282 2007 6823 6832
241. R. Tesla, H.P. Wolf, P. Xu, J. Drawbridge, S.J. Estill, P. Huntington, L. McDaniel, W. Knobbe, A. Burket, S. Tran, and et al. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis Proc. Natl. Acad. Sci. USA 109 2012 17016 17021
242. H.A. Tissenbaum, and L. Guarente Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans Nature 410 2001 227 230
243. K.S. Tummala, A.L. Gomes, M. Yilmaz, O. Graña, L. Bakiri, I. Ruppen, P. Ximénez-Embún, V. Sheshappanavar, M. Rodriguez-Justo, D.G. Pisano, and et al. Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage Cancer Cell 26 2014 826 839
244. S. Tunaru, J. Kero, A. Schaub, C. Wufka, A. Blaukat, K. Pfeffer, and S. Offermanns PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect Nat. Med. 9 2003 352 355
245. E. Turunc Bayrakdar, G. Armagan, Y. Uyanikgil, L. Kanit, E. Koylu, and A. Yalcin Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Aβ(1-42) Cell Biochem. Funct. 32 2014 557 564
246. E. Turunc Bayrakdar, Y. Uyanikgil, L. Kanit, E. Koylu, and A. Yalcin Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease Free Radic. Res. 48 2014 146 158
247. R. Upadhya, J. Lee, and I.M. Willis Maf1 is an essential mediator of diverse signals that repress RNA polymerase III transcription Mol. Cell 10 2002 1489 1494
248. O. Vakhrusheva, C. Smolka, P. Gajawada, S. Kostin, T. Boettger, T. Kubin, T. Braun, and E. Bober Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice Circ. Res. 102 2008 703 710
249. M.T. Valenzuela, R. Guerrero, M.I. Núñez, J.M. Ruiz De Almodóvar, M. Sarker, G. de Murcia, and F.J. Oliver PARP-1 modifies the effectiveness of p53-mediated DNA damage response Oncogene 21 2002 1108 1116
250. J.R. Van Beijnum, P.T.M. Moerkerk, A.J. Gerbers, A.P. De Bruïne, J.-W. Arends, H.R. Hoogenboom, and S.E. Hufton Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer Int. J. Cancer 101 2002 118 127
251. T. van de Weijer, E. Phielix, L. Bilet, E.G. Williams, E.R. Ropelle, A. Bierwagen, R. Livingstone, P. Nowotny, L.M. Sparks, S. Paglialunga, and et al. Evidence for a direct effect of the NAD+ precursor Acipimox on muscle mitochondrial function in humans Diabetes 64 2014 1193 1201
252. C.W. van Roermund, Y. Elgersma, N. Singh, R.J. Wanders, and H.F. Tabak The membrane of peroxisomes in Saccharomyces cerevisiae is impermeable to NAD(H) and acetyl-CoA under in vivo conditions EMBO J. 14 1995 3480 3486
253. H. Vaziri, S.K. Dessain, E. Ng Eaton, S.I. Imai, R.A. Frye, T.K. Pandita, L. Guarente, and R.A. Weinberg hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase Cell 107 2001 149 159
254. E. Verdin, M.D. Hirschey, L.W.S. Finley, and M.C. Haigis Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling Trends Biochem. Sci. 35 2010 669 675
255. R.-H. Wang, K. Sengupta, C. Li, H.-S. Kim, L. Cao, C. Xiao, S. Kim, X. Xu, Y. Zheng, B. Chilton, and et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice Cancer Cell 14 2008 312 323
256. B. Wang, M.K. Hasan, E. Alvarado, H. Yuan, H. Wu, and W.Y. Chen NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response Oncogene 30 2011 907 921
257. J.T. Wang, Z.A. Medress, and B.A. Barres Axon degeneration: molecular mechanisms of a self-destruction pathway J. Cell Biol. 196 2012 7 18
258. G. Wang, T. Han, D. Nijhawan, P. Theodoropoulos, J. Naidoo, S. Yadavalli, H. Mirzaei, A.A. Pieper, J.M. Ready, and S.L. McKnight P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage Cell 158 2014 1324 1334
259. L. Wang, D. Ding, R. Salvi, and J.A. Roth Nicotinamide adenine dinucleotide prevents neuroaxonal degeneration induced by manganese in cochlear organotypic cultures Neurotoxicology 40 2014 65 74
260. O. Warburg, W. Christian, and A. Griese Hydrogen-transferring co-enzyme, its composition and mode of functioning Biochem. Z. 280 1935 157 205
261. M. Watson, A. Roulston, L. Bélec, X. Billot, R. Marcellus, D. Bédard, C. Bernier, S. Branchaud, H. Chan, K. Dairi, and et al. The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors Mol. Cell. Biol. 29 2009 5872 5888
262. A.C. Williams, and R.I.M. Dunbar Big brains, meat, tuberculosis and the nicotinamide switches: co-evolutionary relationships with modern repercussions on longevity and disease? Med. Hypotheses 83 2014 79 87
263. A. Wise, S.M. Foord, N.J. Fraser, A.A. Barnes, N. Elshourbagy, M. Eilert, D.M. Ignar, P.R. Murdock, K. Steplewski, A. Green, and et al. Molecular identification of high and low affinity receptors for nicotinic acid J. Biol. Chem. 278 2003 9869 9874
264. J. Wu, F. Zhang, M. Yan, D. Wu, Q. Yu, Y. Zhang, B. Zhou, M.W. McBurney, and Q. Zhai WldS enhances insulin transcription and secretion via a SIRT1-dependent pathway and improves glucose homeostasis Diabetes 60 2011 3197 3207
265. Y. Wu, E.G. Williams, S. Dubuis, A. Mottis, V. Jovaisaite, S.M. Houten, C.A. Argmann, P. Faridi, W. Wolski, Z. Kutalik, and et al. Multilayered genetic and omics dissection of mitochondrial activity in a mouse reference population Cell 158 2014 1415 1430
266. G.-H. Xie, S.-Y. Rah, S.J. Kim, T.-S. Nam, K.-C. Ha, S.-W. Chae, M.-J. Im, and U.-H. Kim ADP-ribosyl cyclase couples to cyclic AMP signaling in the cardiomyocytes Biochem. Biophys. Res. Commun. 330 2005 1290 1298
267. N. Yahata, S. Yuasa, and T. Araki Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration J. Neurosci. 29 2009 6276 6284
268. J.A. Yalowitz, S. Xiao, M.P. Biju, A.C. Antony, O.W. Cummings, M.A. Deeg, and H.N. Jayaram Characterization of human brain nicotinamide 5′-mononucleotide adenylyltransferase-2 and expression in human pancreas Biochem. J. 377 2004 317 326
269. H. Yamamoto, Y. Uchigata, and H. Okamoto Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets Nature 294 1981 284 286
270. T. Yan, Y. Feng, J. Zheng, X. Ge, Y. Zhang, D. Wu, J. Zhao, and Q. Zhai Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity Neurochem. Int. 56 2010 101 106
271. H. Yang, T. Yang, J.A. Baur, E. Perez, T. Matsui, J.J. Carmona, D.W. Lamming, N.C. Souza-Pinto, V.A. Bohr, A. Rosenzweig, and et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival Cell 130 2007 1095 1107
272. T. Yang, N.Y. Chan, and A.A. Sauve Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells J. Med. Chem. 50 2007 6458 6461
273. S.J. Yang, J.M. Choi, L. Kim, S.E. Park, E.J. Rhee, W.Y. Lee, K.W. Oh, S.W. Park, and C.-Y. Park Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes J. Nutr. Biochem. 25 2014 66 72
274. F. Yeung, J.E. Hoberg, C.S. Ramsey, M.D. Keller, D.R. Jones, R.A. Frye, and M.W. Mayo Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J. 23 2004 2369 2380
275. T.C. Yin, J.K. Britt, H. De Jesús-Cortés, Y. Lu, R.M. Genova, M.Z. Khan, J.R. Voorhees, J. Shao, A.C. Katzman, P.J. Huntington, and et al. P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury Cell Rep. 8 2014 1731 1740
276. W. Ying NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences Antioxid. Redox Signal. 10 2008 179 206
277. W. Ying, C.C. Alano, P. Garnier, and R.A. Swanson NAD+ as a metabolic link between DNA damage and cell death J. Neurosci. Res. 79 2005 216 223
278. M.J. Yoon, M. Yoshida, S. Johnson, A. Takikawa, I. Usui, K. Tobe, T. Nakagawa, J. Yoshino, and S.-i. Imai SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD(+) and Function in Mice Cell Metab. 21 2015 706 717
279. J. Yoshino, K.F. Mills, M.J. Yoon, and S. Imai Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice Cell Metab. 14 2011 528 536
280. J. Yu, S. Sadhukhan, L.G. Noriega, N. Moullan, B. He, R.S. Weiss, H. Lin, K. Schoonjans, and J. Auwerx Metabolic characterization of a Sirt5 deficient mouse model Sci. Rep. 3 2013 10.1038/srep02806
281. Q. Zhang, D.W. Piston, and R.H. Goodman Regulation of corepressor function by nuclear NADH Science 295 2002 1895 1897
282. X. Zhang, O.V. Kurnasov, S. Karthikeyan, N.V. Grishin, A.L. Osterman, and H. Zhang Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis J. Biol. Chem. 278 2003 13503 13511
283. Y. Zhang, R.J. Schmidt, P. Foxworthy, R. Emkey, J.K. Oler, T.H. Large, H. Wang, E.W. Su, M.K. Mosior, P.I. Eacho, and G. Cao Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74A Biochem. Biophys. Res. Commun. 334 2005 729 732
284. T. Zhang, J.G. Berrocal, K.M. Frizzell, M.J. Gamble, M.E. DuMond, R. Krishnakumar, T. Yang, A.A. Sauve, and W.L. Kraus Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters J. Biol. Chem. 284 2009 20408 20417
285. L.Q. Zhang, D.P. Heruth, and S.Q. Ye Nicotinamide phosphoribosyltransferase in human diseases J. Bioanal. Biomed. 3 2011 13 25
286. T. Zhang, J.G. Berrocal, J. Yao, M.E. DuMond, R. Krishnakumar, D.D. Ruhl, K.W. Ryu, M.J. Gamble, and W.L. Kraus Regulation of poly(ADP-ribose) polymerase-1-dependent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase J. Biol. Chem. 287 2012 12405 12416
287. F. Zhang, R. Xie, F.M. Munoz, S.S. Lau, and T.J. Monks PARP-1 hyperactivation and reciprocal elevations in intracellular Ca2+ during ros-induced nonapoptotic cell death Toxicol Sci. 140 2014 118 134
288. Y.J. Zhao, C.M.C. Lam, and H.C. Lee The membrane-bound enzyme CD38 exists in two opposing orientations Sci. Signal. 5 2012 ra67
289. L. Zhong, A. D'Urso, D. Toiber, C. Sebastian, R.E. Henry, D.D. Vadysirisack, A. Guimaraes, B. Marinelli, J.D. Wikstrom, T. Nir, and et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha Cell 140 2010 280 293
290. M. Zhou, G. Ottenberg, G.F. Sferrazza, C. Hubbs, M. Fallahi, G. Rumbaugh, A.F. Brantley, and C.I. Lasmézas Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment Brain 138 2015 992 1008